269 related articles for article (PubMed ID: 23087177)
1. PD-1 is a novel regulator of human B-cell activation.
Thibult ML; Mamessier E; Gertner-Dardenne J; Pastor S; Just-Landi S; Xerri L; Chetaille B; Olive D
Int Immunol; 2013 Feb; 25(2):129-37. PubMed ID: 23087177
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis.
Wilde B; Hua F; Dolff S; Jun C; Cai X; Specker C; Feldkamp T; Kribben A; Cohen Tervaert JW; Witzke O
Rheumatology (Oxford); 2012 Jul; 51(7):1188-97. PubMed ID: 22447882
[TBL] [Abstract][Full Text] [Related]
3. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.
Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA
Allergy; 2013; 68(5):593-603. PubMed ID: 23480796
[TBL] [Abstract][Full Text] [Related]
4. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
[TBL] [Abstract][Full Text] [Related]
5. Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells.
Dirks J; Egli A; Sester U; Sester M; Hirsch HH
Transpl Infect Dis; 2013 Feb; 15(1):79-89. PubMed ID: 23176118
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of B-cell activation and antibody production by triggering inhibitory signals via the PD-1/PD-ligand pathway.
Buermann A; Römermann D; Baars W; Hundrieser J; Klempnauer J; Schwinzer R
Xenotransplantation; 2016 Sep; 23(5):347-56. PubMed ID: 27613101
[TBL] [Abstract][Full Text] [Related]
7. Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic manner.
Charlton JJ; Chatzidakis I; Tsoukatou D; Boumpas DT; Garinis GA; Mamalaki C
J Immunol; 2013 Jun; 190(12):6104-14. PubMed ID: 23686498
[TBL] [Abstract][Full Text] [Related]
8. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.
Badoual C; Hans S; Merillon N; Van Ryswick C; Ravel P; Benhamouda N; Levionnois E; Nizard M; Si-Mohamed A; Besnier N; Gey A; Rotem-Yehudar R; Pere H; Tran T; Guerin CL; Chauvat A; Dransart E; Alanio C; Albert S; Barry B; Sandoval F; Quintin-Colonna F; Bruneval P; Fridman WH; Lemoine FM; Oudard S; Johannes L; Olive D; Brasnu D; Tartour E
Cancer Res; 2013 Jan; 73(1):128-38. PubMed ID: 23135914
[TBL] [Abstract][Full Text] [Related]
9. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory signals mediated by programmed death-1 are involved with T-cell function in chronic periodontitis.
Figueira EA; de Rezende ML; Torres SA; Garlet GP; Lara VS; Santos CF; Avila-Campos MJ; da Silva JS; Campanelli AP
J Periodontol; 2009 Nov; 80(11):1833-44. PubMed ID: 19905953
[TBL] [Abstract][Full Text] [Related]
11. PD-L2 is expressed on activated human T cells and regulates their function.
Messal N; Serriari NE; Pastor S; Nunès JA; Olive D
Mol Immunol; 2011 Sep; 48(15-16):2214-9. PubMed ID: 21752471
[TBL] [Abstract][Full Text] [Related]
12. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
13. Germinal center cells are a major IL-5-responsive B cell population in peripheral lymph nodes engaged in the immune response.
Rabinowitz JL; Tsiagbe VK; Nicknam MH; Thorbecke GJ
J Immunol; 1990 Oct; 145(8):2440-7. PubMed ID: 2212647
[TBL] [Abstract][Full Text] [Related]
14. Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors.
Petterson T; Jendholm J; Månsson A; Bjartell A; Riesbeck K; Cardell LO
J Leukoc Biol; 2011 Feb; 89(2):177-87. PubMed ID: 20844241
[TBL] [Abstract][Full Text] [Related]
15. Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger.
Zhong X; Bai C; Gao W; Strom TB; Rothstein TL
Int Immunol; 2004 Aug; 16(8):1181-8. PubMed ID: 15237109
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.
Augello A; Tasso R; Negrini SM; Amateis A; Indiveri F; Cancedda R; Pennesi G
Eur J Immunol; 2005 May; 35(5):1482-90. PubMed ID: 15827960
[TBL] [Abstract][Full Text] [Related]
17. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.
Jiang W; Lederman MM; Harding CV; Rodriguez B; Mohner RJ; Sieg SF
Eur J Immunol; 2007 Aug; 37(8):2205-13. PubMed ID: 17621369
[TBL] [Abstract][Full Text] [Related]
18. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
20. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
